Keating MJ - Search Results

1

Clinical characteristics, response to therapy, and survival of African American patients diagnosed with chronic lymphocytic leukemia: joint experience of the MD Anderson Cancer Center and Duke University Medical Center.

Falchi L, Keating MJ, Wang X, Coombs CC, Lanasa MC, Strom S, Wierda WG, Ferrajoli A. Falchi L, et al. Among authors: keating mj. Cancer. 2013 Sep 1;119(17):3177-85. doi: 10.1002/cncr.28030. Epub 2013 Jul 8. Cancer. 2013. PMID: 24022787 Free PMC article.

2

Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic, and molecular analysis.

Robertson LE, Huh YO, Butler JJ, Pugh WC, Hirsch-Ginsberg C, Stass S, Kantarjian H, Keating MJ. Robertson LE, et al. Among authors: keating mj. Blood. 1992 Jul 1;80(1):29-36. Blood. 1992. PMID: 1377051 Free article.

3

Fludarabine infusion potentiates arabinosylcytosine metabolism in lymphocytes of patients with chronic lymphocytic leukemia.

Gandhi V, Kemena A, Keating MJ, Plunkett W. Gandhi V, et al. Among authors: keating mj. Cancer Res. 1992 Feb 15;52(4):897-903. Cancer Res. 1992. PMID: 1737352

4

Therapeutic approaches to chronic lymphocytic leukemia.

Robertson LE, Keating MJ. Robertson LE, et al. Among authors: keating mj. Tex Med. 1991 Nov;87(11):68-74. Tex Med. 1991. PMID: 1759245 Review.

5

Mitoxantrone and high-dose etoposide for patients with relapsed or refractory acute leukemia.

O'Brien S, Kantarjian H, Estey E, Koller C, Beran M, McCredie K, Keating M. O'Brien S, et al. Cancer. 1991 Aug 15;68(4):691-4. doi: 10.1002/1097-0142(19910815)68:4<691::aid-cncr2820680404>3.0.co;2-z. Cancer. 1991. PMID: 1855168

6

Intensive chemotherapy induction followed by interferon-alpha maintenance in patients with Philadelphia chromosome-positive chronic myelogenous leukemia.

Kantarjian HM, Talpaz M, Keating MJ, Estey EH, O'Brien S, Beran M, McCredie KB, Gutterman J, Freireich EJ. Kantarjian HM, et al. Among authors: keating mj. Cancer. 1991 Sep 15;68(6):1201-7. doi: 10.1002/1097-0142(19910915)68:6<1201::aid-cncr2820680604>3.0.co;2-1. Cancer. 1991. PMID: 1873771

7

Phase I clinical investigation of benzisoquinolinedione (amonafide) in adults with refractory or relapsed acute leukemia.

O'Brien S, Benvenuto JA, Estey E, Beran M, Felder TB, Keating M. O'Brien S, et al. Cancer Res. 1991 Feb 1;51(3):935-8. Cancer Res. 1991. PMID: 1988134 Clinical Trial.

8

Fludarabine therapy in hairy cell leukemia.

Kantarjian HM, Schachner J, Keating MJ. Kantarjian HM, et al. Among authors: keating mj. Cancer. 1991 Mar 1;67(5):1291-3. doi: 10.1002/1097-0142(19910301)67:5<1291::aid-cncr2820670503>3.0.co;2-y. Cancer. 1991. PMID: 1991291

9

Exposure histories in acute nonlymphocytic leukemia patients with a prior preleukemic condition.

Crane MM, Keating MJ. Crane MM, et al. Among authors: keating mj. Cancer. 1991 Apr 15;67(8):2211-4. doi: 10.1002/1097-0142(19910415)67:8<2211::aid-cncr2820670835>3.0.co;2-4. Cancer. 1991. PMID: 2004342

10

Pharmacologically directed design of the dose rate and schedule of 2',2'-difluorodeoxycytidine (Gemcitabine) administration in leukemia.

Grunewald R, Kantarjian H, Keating MJ, Abbruzzese J, Tarassoff P, Plunkett W. Grunewald R, et al. Among authors: keating mj. Cancer Res. 1990 Nov 1;50(21):6823-6. Cancer Res. 1990. PMID: 2208147

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

895 results

Search Page

Filters